Skip to main content
    Z

    Zoetis Inc (ZTS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $84.42
    +0.61 (+0.72%)

    Market Cap: $34.06B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zoetis Inc (ZTS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Zoetis (ZTS) to earn $6.29 per share in the fiscal year ending Dec 31, 2026, on revenue of $9.29B. Of 16 analysts, 5 rate the stock Buy or Strong Buy, 11 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 7 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 16 ratings average 2.50, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 31% of the ratings.

    RatingAnalystsShare
    Strong Buy318.8%
    Buy212.5%
    Hold1168.8%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    16

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 1.4% and revenue estimates rise 0.5%.

    Fiscal year ending Dec 31, 2026
    $6.29
    EPS consensus, revenue $9.29B
    Fiscal year ending Dec 31, 2027
    $6.38
    EPS consensus, revenue $9.34B
    Next report
    Feb 10, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$6.29$6.19 to $6.3714$9.29B$9.23B to $9.32B13
    Dec 31, 2027$6.38$5.96 to $7.4815$9.34B$9.01B to $10.17B14

    Quarterly Estimates

    The EPS consensus rises from $1.20 for the quarter ending Dec 31, 2026 to $1.50 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$1.20$1.12 to $1.3515$2.20B$2.10B to $2.35B13
    Mar 31, 2027$1.50$1.41 to $1.579$2.24B$2.18B to $2.29B7

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 8 upward and 8 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202670
    Fiscal year ending Dec 31, 202716
    Quarter ending Mar 31, 202702

    EPS Trend

    The EPS consensus for the fiscal year ending Dec 31, 2026 is where it was 90 days ago.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$6.29$6.26$6.21$6.21$6.29+0.1%
    Fiscal year ending Dec 31, 2027$6.38$6.41$6.54$6.53$6.73-5.3%
    Quarter ending Mar 31, 2027$1.50$1.50$1.52$1.52$1.57-4.8%

    Frequently Asked Questions About ZTS

    What is the ZTS stock forecast?

    Consensus analyst estimates put Zoetis's EPS at $6.29 for the fiscal year ending Dec 31, 2026, on revenue of $9.29B. The consensus rating from 16 analysts is Hold.

    How do analysts rate ZTS stock?

    Of 16 analysts covering Zoetis, 3 rate it Strong Buy, 2 Buy, 11 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from ZTS next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $6.29, with estimates from $6.19 to $6.37 from 14 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $6.38, with estimates from $5.96 to $7.48 from 15 analysts.

    What revenue do analysts expect from Zoetis next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $9.29B, with estimates from $9.23B to $9.32B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $9.34B, with estimates from $9.01B to $10.17B.

    How many analysts cover ZTS?

    16 analysts rate Zoetis stock, and 14 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.